HGH, PRL, and ACTH Gene Expression in Clinically Nonfunctioning Adenomas Detected with Nonisotopic In Situ Hybridization Method
- PMID: 12114686
- DOI: 10.1007/BF02914985
HGH, PRL, and ACTH Gene Expression in Clinically Nonfunctioning Adenomas Detected with Nonisotopic In Situ Hybridization Method
Abstract
In situ hybridization (ISH), which can manifest the specific gene expression of anterior pituitary hormones (mRNA), as well as immunohistochemistry (IHC), is needed to clarify the endocrine function of pituitary adenomas. With the aid of nonisotopic ISH, which has several advantages over isotopic ISH, we examined the expression of pituitary hormone mRNAs in 14 clinically nonfunctioning adenomas, which were considered to be a subtype of gonadotroph adenomas. Gene expression of growth hormone (GH; 4/14), prolactin (PRL; 5/14), adrenocorticotroph hormone (ACTH; 4/14), and gonadotropin were detected with our nonisotopic ISH studies. It is suggested from our ISH studies that some clinically nonfunctioning adenomas are composed of hormone (or subunit) producing cells and may be derived from plurihormonal primordial stem cells.
Similar articles
-
A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.Acta Neurochir (Wien). 1996;138(8):1002-7. doi: 10.1007/BF01411291. Acta Neurochir (Wien). 1996. PMID: 8890999
-
Expression of plurihormonal mRNAs in somatotrophic adenomas detected using a nonisotopic in situ hybridization method: comparison with lactotrophic adenomas.Hum Pathol. 1995 Mar;26(3):272-9. doi: 10.1016/0046-8177(95)90057-8. Hum Pathol. 1995. PMID: 7890277
-
HGH, PRL and beta HCG/beta LH gene expression in clinically inactive pituitary adenomas detected by in situ hybridization.Virchows Arch A Pathol Anat Histopathol. 1991;418(5):405-10. doi: 10.1007/BF01605926. Virchows Arch A Pathol Anat Histopathol. 1991. PMID: 1709764
-
GH-, PRL-, POMC-, beta-TSH-, beta-LH-, beta-FSH-mRNA in gonadotroph adenomas of the pituitary by in situ hybridization in comparison with immunostaining and clinical data.Endocr Pathol. 2001 Summer;12(2):171-80. doi: 10.1385/ep:12:2:171. Endocr Pathol. 2001. PMID: 11579683
-
Diagnosis and treatment of pituitary adenomas.Minerva Endocrinol. 2004 Dec;29(4):241-75. Minerva Endocrinol. 2004. PMID: 15765032 Review.
Cited by
-
Immunohistochemical Analyses of Mammalian Target of Rapamycin (mTOR) Expression in Pituitary Neuroendocrine Tumors (PitNETs): mTOR as a Therapeutic Target for Functional PitNETs.Acta Histochem Cytochem. 2023 Dec 28;56(6):121-126. doi: 10.1267/ahc.23-00039. Epub 2023 Dec 20. Acta Histochem Cytochem. 2023. PMID: 38318106 Free PMC article.
-
A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.Acta Neurochir (Wien). 1996;138(8):1002-7. doi: 10.1007/BF01411291. Acta Neurochir (Wien). 1996. PMID: 8890999
-
Acromegaly due to a Macroinvasive Plurihormonal Pituitary Adenoma and a Rectal Carcinoid Tumor.Endocrinol Metab (Seoul). 2015 Sep;30(3):389-94. doi: 10.3803/EnM.2015.30.3.389. Epub 2015 Jan 5. Endocrinol Metab (Seoul). 2015. PMID: 25559714 Free PMC article.
-
Clinical and cytofunctional classification of pituitary adenomas: proposal of a new classification.Acta Neurochir (Wien). 1996;138(10):1186-92. doi: 10.1007/BF01809749. Acta Neurochir (Wien). 1996. PMID: 8955438
-
Simultaneous ultrastructural identification of growth hormone and its messenger ribonucleic acid using combined immunohistochemistry and non-radioisotopic in situ hybridization: a technical note.Histochem J. 1996 Oct;28(10):703-7. doi: 10.1007/BF02409007. Histochem J. 1996. PMID: 8950599